TY - JOUR
T1 - POEMS Syndrome
T2 - Diagnosis and Investigative Work-up
AU - Dispenzieri, Angela
AU - Kourelis, Taxiarchis
AU - Buadi, Francis
N1 - Publisher Copyright:
© 2017 Elsevier Inc.
PY - 2018/2
Y1 - 2018/2
N2 - POEMS syndrome is a rare paraneoplastic syndrome secondary to a plasma cell dyscrasia. Recognition of a combination of peripheral neuropathy, organomegaly, endocrinopathy, monoclonal plasmaproliferative disorder, skin changes, papilledema, extravascular volume overload, sclerotic bone lesions, thrombocytosis, and Castleman disease is the first step in managing the disease. Increased blood levels of vascular endothelial growth factor are usually confirmatory. This rare disorder should not be missed, especially if the patient has a putative diagnosis of chronic inflammatory polyradiculoneuropathy, a lambda restricted monoclonal gammopathy, and thrombocytosis, and is not responding as expected to immunomodulatory therapy commonly used for chronic inflammatory polyradiculoneuropathy.
AB - POEMS syndrome is a rare paraneoplastic syndrome secondary to a plasma cell dyscrasia. Recognition of a combination of peripheral neuropathy, organomegaly, endocrinopathy, monoclonal plasmaproliferative disorder, skin changes, papilledema, extravascular volume overload, sclerotic bone lesions, thrombocytosis, and Castleman disease is the first step in managing the disease. Increased blood levels of vascular endothelial growth factor are usually confirmatory. This rare disorder should not be missed, especially if the patient has a putative diagnosis of chronic inflammatory polyradiculoneuropathy, a lambda restricted monoclonal gammopathy, and thrombocytosis, and is not responding as expected to immunomodulatory therapy commonly used for chronic inflammatory polyradiculoneuropathy.
KW - Castleman disease
KW - Chronic inflammatory polyradiculoneuropathy
KW - Paraneoplastic
KW - Plasma cell disorder
UR - http://www.scopus.com/inward/record.url?scp=85034968624&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85034968624&partnerID=8YFLogxK
U2 - 10.1016/j.hoc.2017.09.010
DO - 10.1016/j.hoc.2017.09.010
M3 - Review article
C2 - 29157614
AN - SCOPUS:85034968624
SN - 0889-8588
VL - 32
SP - 119
EP - 139
JO - Hematology/Oncology Clinics of North America
JF - Hematology/Oncology Clinics of North America
IS - 1
ER -